{"id":31318,"date":"2018-10-11T03:36:20","date_gmt":"2018-10-11T07:36:20","guid":{"rendered":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/?p=31318"},"modified":"2018-10-11T16:54:15","modified_gmt":"2018-10-11T20:54:15","slug":"angiodynamics-expands-its-oncology-business-with-purchase-of-the-radiadyne-company","status":"publish","type":"post","link":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/2018\/10\/angiodynamics-expands-its-oncology-business-with-purchase-of-the-radiadyne-company\/","title":{"rendered":"AngioDynamics Expands Its Oncology Business With Purchase Of The RadiaDyne Company"},"content":{"rendered":"<p class=\"p1\"><span class=\"s1\">AngioDynamics Inc., a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology, has an agreement to acquire RadiaDyne, a privately held medical diagnostic and device company that designs and develops patient dose monitoring technology to improve cancer treatment outcomes.<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">The transaction expands AngioDynamics\u2019 growing oncology business by adding RadiaDyne\u2019s early-stage, proprietary OARtrac, real-time radiation dose monitoring platform, and other market-leading oncology solutions, including the IsoLoc\/ImmobiLoc and Alatus balloon stabilizing technologies.<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">\u201cThe acquisition of RadiaDyne, combined with our recent BioSentry asset purchase, delivers on our commitment to build a world-class oncology portfolio,\u201d said Jim Clemmer, president and chief executive officer of AngioDynamics. <\/span><!--more--><\/p>\n<p class=\"p1\"><span class=\"s1\">\u201cWe believe that together, these disruptive, patient-focused technologies will deliver safer, clinically-relevant, economically-favorable solutions for patients,\u201d he said. \u201cThis combination will significantly expand our value proposition and meaningfully change how care is delivered.\u201d<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">RadiaDyne\u2019s recently launched OARtrac system provides precise, real-time measurement via a proprietary intracavitary device. The system delivers critical dose feedback to medical and radiation oncologists, providing customized adaptive radiotherapy, reduced side effects, and improved clinical outcomes across all forms of radiation and photon beam therapy.<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">RadiaDyne\u2019s endorectal technology, IsoLoc\/ImmobiLoc, removes transient rectal gas using a patented gas-release tip and reliably reduces prostate motion and radiation toxicity. <\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">RadiaDyne\u2019s Alatus vaginal balloon packing system provides physicians with an improved method for optimal dosimetry protection and decreased complications. Both patient-centric technologies improve clinical outcomes and are used widely in practice today.<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">\u201cWe are excited that AngioDynamics chose to acquire RadiaDyne,\u201d said John Isham, founder and chief executive officer of RadiaDyne. \u201cWe are proud of our technologies, which improve radiation delivery and lower side effects for patients undergoing radiation therapy for cancer treatment. This partnership immediately strengthens our commercial infrastructure, allowing us to deliver the benefits of our innovative products to a wider patient population.\u201d<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">RadiaDyne\u2019s trailing 12-month revenues exceeded $6 million The acquisition was expected to close by the end of September and be neutral to earnings on an adjusted basis.<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">Deutsche Bank Securities Inc. served as the exclusive financial advisor to AngioDynamics.<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">AngioDynamics\u2019 diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories drainage products, thrombolytic products and venous products. <\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">For more information, visit www.angiodynamics.com.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>AngioDynamics Inc., a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology, has an agreement to acquire RadiaDyne, a privately held medical diagnostic and device company that designs and develops patient dose monitoring technology to improve cancer treatment outcomes. The transaction expands AngioDynamics\u2019 growing oncology business by adding [&hellip;]<\/p>\n","protected":false},"author":89,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\r\n<title>AngioDynamics Expands Its Oncology Business With Purchase Of The RadiaDyne Company - Glens Falls Business Journal<\/title>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/2018\/10\/angiodynamics-expands-its-oncology-business-with-purchase-of-the-radiadyne-company\/\" \/>\r\n<meta property=\"og:locale\" content=\"en_US\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"AngioDynamics Expands Its Oncology Business With Purchase Of The RadiaDyne Company - Glens Falls Business Journal\" \/>\r\n<meta property=\"og:description\" content=\"AngioDynamics Inc., a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology, has an agreement to acquire RadiaDyne, a privately held medical diagnostic and device company that designs and develops patient dose monitoring technology to improve cancer treatment outcomes. The transaction expands AngioDynamics\u2019 growing oncology business by adding [&hellip;]\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/2018\/10\/angiodynamics-expands-its-oncology-business-with-purchase-of-the-radiadyne-company\/\" \/>\r\n<meta property=\"og:site_name\" content=\"Glens Falls Business Journal\" \/>\r\n<meta property=\"article:published_time\" content=\"2018-10-11T07:36:20+00:00\" \/>\r\n<meta property=\"article:modified_time\" content=\"2018-10-11T20:54:15+00:00\" \/>\r\n<meta name=\"author\" content=\"Jake Van Ness\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jake Van Ness\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/2018\/10\/angiodynamics-expands-its-oncology-business-with-purchase-of-the-radiadyne-company\/\",\"url\":\"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/2018\/10\/angiodynamics-expands-its-oncology-business-with-purchase-of-the-radiadyne-company\/\",\"name\":\"AngioDynamics Expands Its Oncology Business With Purchase Of The RadiaDyne Company - Glens Falls Business Journal\",\"isPartOf\":{\"@id\":\"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/#website\"},\"datePublished\":\"2018-10-11T07:36:20+00:00\",\"dateModified\":\"2018-10-11T20:54:15+00:00\",\"author\":{\"@id\":\"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/#\/schema\/person\/a11ec438b5f0e57f1156754ba3931b86\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/2018\/10\/angiodynamics-expands-its-oncology-business-with-purchase-of-the-radiadyne-company\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/2018\/10\/angiodynamics-expands-its-oncology-business-with-purchase-of-the-radiadyne-company\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/2018\/10\/angiodynamics-expands-its-oncology-business-with-purchase-of-the-radiadyne-company\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AngioDynamics Expands Its Oncology Business With Purchase Of The RadiaDyne Company\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/#website\",\"url\":\"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/\",\"name\":\"Glens Falls Business Journal\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/#\/schema\/person\/a11ec438b5f0e57f1156754ba3931b86\",\"name\":\"Jake Van Ness\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/8083519989e12032abdd06a668982ef4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/8083519989e12032abdd06a668982ef4?s=96&d=mm&r=g\",\"caption\":\"Jake Van Ness\"},\"url\":\"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/author\/jakev\/\"}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AngioDynamics Expands Its Oncology Business With Purchase Of The RadiaDyne Company - Glens Falls Business Journal","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/2018\/10\/angiodynamics-expands-its-oncology-business-with-purchase-of-the-radiadyne-company\/","og_locale":"en_US","og_type":"article","og_title":"AngioDynamics Expands Its Oncology Business With Purchase Of The RadiaDyne Company - Glens Falls Business Journal","og_description":"AngioDynamics Inc., a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology, has an agreement to acquire RadiaDyne, a privately held medical diagnostic and device company that designs and develops patient dose monitoring technology to improve cancer treatment outcomes. The transaction expands AngioDynamics\u2019 growing oncology business by adding [&hellip;]","og_url":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/2018\/10\/angiodynamics-expands-its-oncology-business-with-purchase-of-the-radiadyne-company\/","og_site_name":"Glens Falls Business Journal","article_published_time":"2018-10-11T07:36:20+00:00","article_modified_time":"2018-10-11T20:54:15+00:00","author":"Jake Van Ness","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Jake Van Ness","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/2018\/10\/angiodynamics-expands-its-oncology-business-with-purchase-of-the-radiadyne-company\/","url":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/2018\/10\/angiodynamics-expands-its-oncology-business-with-purchase-of-the-radiadyne-company\/","name":"AngioDynamics Expands Its Oncology Business With Purchase Of The RadiaDyne Company - Glens Falls Business Journal","isPartOf":{"@id":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/#website"},"datePublished":"2018-10-11T07:36:20+00:00","dateModified":"2018-10-11T20:54:15+00:00","author":{"@id":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/#\/schema\/person\/a11ec438b5f0e57f1156754ba3931b86"},"breadcrumb":{"@id":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/2018\/10\/angiodynamics-expands-its-oncology-business-with-purchase-of-the-radiadyne-company\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/2018\/10\/angiodynamics-expands-its-oncology-business-with-purchase-of-the-radiadyne-company\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/2018\/10\/angiodynamics-expands-its-oncology-business-with-purchase-of-the-radiadyne-company\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/"},{"@type":"ListItem","position":2,"name":"AngioDynamics Expands Its Oncology Business With Purchase Of The RadiaDyne Company"}]},{"@type":"WebSite","@id":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/#website","url":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/","name":"Glens Falls Business Journal","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/#\/schema\/person\/a11ec438b5f0e57f1156754ba3931b86","name":"Jake Van Ness","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/8083519989e12032abdd06a668982ef4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8083519989e12032abdd06a668982ef4?s=96&d=mm&r=g","caption":"Jake Van Ness"},"url":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/author\/jakev\/"}]}},"_links":{"self":[{"href":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/wp-json\/wp\/v2\/posts\/31318"}],"collection":[{"href":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/wp-json\/wp\/v2\/users\/89"}],"replies":[{"embeddable":true,"href":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/wp-json\/wp\/v2\/comments?post=31318"}],"version-history":[{"count":1,"href":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/wp-json\/wp\/v2\/posts\/31318\/revisions"}],"predecessor-version":[{"id":31319,"href":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/wp-json\/wp\/v2\/posts\/31318\/revisions\/31319"}],"wp:attachment":[{"href":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/wp-json\/wp\/v2\/media?parent=31318"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/wp-json\/wp\/v2\/categories?post=31318"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.glensfalls.com\/glensfallsbusinessjournal\/wp-json\/wp\/v2\/tags?post=31318"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}